"Popular" and "proven" are not always the same thing in ED treatment. This guide ranks the common options by how strong the evidence behind them actually is — so the popularity makes sense rather than just following marketing.
First-Line: PDE5 Inhibitors
Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are the evidence-backed core. The American Urological Association names this drug class first-line ED therapy where it is not contraindicated. They work by blocking the PDE5 enzyme to improve blood flow in response to arousal — they do not create desire on their own.
Why they lead: decades of data, high response rates, and options that fit different patterns — fast-acting sildenafil for planned use, long-acting tadalafil (about 17.5-hour half-life) for spontaneity or daily dosing. The one non-negotiable: they are contraindicated with nitrates, which is why a real medical review precedes any prescription.
Foundational: Lifestyle Change
NIDDK is clear that diet, exercise, weight management, and cutting smoking and excess alcohol can lower ED risk and improve symptoms. It is the one "treatment" with no prescription, no cost, and broad health benefits beyond ED — and because ED often shares roots with cardiovascular disease, these changes address cause, not just symptom. It works best alongside medication, not as a replacement for evaluation when ED is persistent.
Conditional: Testosterone Replacement Therapy
TRT is not an ED treatment for most men. It helps a specific subset whose ED is tied to clinically low testosterone, and it is prescribed to only a small share of U.S. men. Critically, ED and low testosterone are distinct conditions; PDE5 inhibitors are not testosterone and do not raise it. TRT belongs in the conversation only after appropriate testing confirms a hormonal driver.
Emerging and Unproven
Shockwave therapy (Li-ESWT) and platelet-rich plasma ("P-shot") injections are studied for repairing blood flow, but the evidence is still developing and they are not established first-line care. Acupuncture and herbal supplements have weaker and less consistent support. Treat these as experimental adjuncts to discuss with a clinician — not substitutes for proven options.
Conclusion
For most men, the ranking is straightforward: a PDE5 inhibitor plus lifestyle change resolves or manages ED effectively, with TRT and emerging therapies reserved for specific situations. The right starting point is an evaluation that rules out underlying causes. Compare evidence-backed ED treatment options and bring your full medical history to the conversation.
Sources used for medical context
- PDE5 Inhibitors (StatPearls, NCBI) for first-line status and contraindications.
- NIDDK — Symptoms & Causes for lifestyle factors and underlying causes.
- AHA Circulation for drug pharmacology.
